Welton, Joanne, Morgan, Matthew, Martí, Salvador, Stone, Michael, Moser, Bernhard ORCID: https://orcid.org/0000-0002-4354-4572, Sewell, Andrew K. ORCID: https://orcid.org/0000-0003-3194-3135, Turton, Jane and Eberl, Matthias ORCID: https://orcid.org/0000-0002-9390-5348 2013. Monocytes and γδ T cells control the acute phase response to intravenous zoledronate: insights from a phase IV safety trial. Journal of Bone and Mineral Research (JBMR) 28 (3) , pp. 464-471. 10.1002/jbmr.1797 |
Preview |
PDF
- Published Version
Download (237kB) | Preview |
Abstract
Aminobisphosphonates (NBPs) are used widely against excessive bone resorption in osteoporosis and Paget’s disease as well as in metastatic bone disease and multiple myeloma. Intravenous NBP administration often causes mild to severe acute phase responses (APRs) that may require intervention with analgesics and antipyretics and lead to treatment noncompliance and non-adherence. We here undertook a phase IV safety trial in patients with osteoporosis to investigate the APR of otherwise healthy individuals to first-time intravenous treatment with the NBP zoledronate. This study provides unique insight into sterile acute inflammatory responses in vivo, in the absence of confounding factors such as infection or cancer. Our data show that both peripheral
Item Type: | Article |
---|---|
Date Type: | Publication |
Status: | Published |
Schools: | Medicine Systems Immunity Research Institute (SIURI) |
Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
Uncontrolled Keywords: | AminobiSsphosphonates; γδ T cells; acute-phase response; osteoporosis; immunotherapy |
Publisher: | American Society for Bone and Mineral Research |
ISSN: | 0884-0431 |
Date of First Compliant Deposit: | 30 March 2016 |
Last Modified: | 21 Nov 2024 13:27 |
URI: | https://orca.cardiff.ac.uk/id/eprint/41413 |
Citation Data
Cited 53 times in Scopus. View in Scopus. Powered By Scopus® Data
Actions (repository staff only)
Edit Item |